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Societal Impact Statement
Biodiversity loss is happening at an unprecedented rate. Understanding and protect-
ing biodiversity has never been more urgent, and scientific research is key to this. Fair 
and transparent access and benefit sharing policies enable research to take place, 
whilst supporting sustainable livelihoods of communities and ensuring benefits are 
shared. Current national legislation has been unevenly implemented and, in this arti-
cle, we recommend frameworks be developed to standardize the provision and use 
of genetic resources for non-commercial research.
Summary: 
• Access to genetic resources for scientific research is vital to support and pro-
mote the conservation and sustainable use of the world's biodiversity. The regu-
latory framework for research is stipulated by Access and Benefit Sharing (ABS) 
legislation at a national level, but other elements – legal transparency, respect, 
cooperation, and trust – are essential for its effective and sustainable implemen-
tation. Despite the intention of this “ABS regime” to protect natural resources and 
associated knowledge from misappropriation, several studies have questioned 
whether national regulatory approaches have led to constraints on research and 
conservation.
• We analyse evidence and provide case studies on how these regulations are affect-
ing research. We find that the number of Internationally Recognized Certificates 
of Compliance (IRCC) of the Nagoya Protocol (NP), the key compliance mechanism 
of the ABS system, doubled in the six months prior to February 2020 and analyse 
why this may be the case.
• Additionally, a survey of the Convention on International Trade in Endangered 
Species of Wild Fauna and Flora (CITES) Authorities in 28 countries, found differ-
ences in the way the Registered Scientific Institute scheme is interpreted and used 
to facilitate scientific research.
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1  | BACKGROUND
There is an urgent need to halt biodiversity loss (Bongaarts, 2019; 
Mace et al., 2018). We focus on two key biodiversity conservation 
conventions: The Convention on Biological Diversity (CBD) and the 
Convention on International Trade in Endangered Species of Wild 
Fauna and Flora (CITES). We examine whether adequate measures 
are in place to ensure the conventions support and enable the re-
search vital to combatting biodiversity loss.
While Article 15 of the CBD states the authority to determine 
access to genetic resources rests with the national governments’, 
this article looks at how different countries have reacted to both the 
CBD and the Nagoya Protocol (NP) promoting simplified measures 
for non-commercial research purposes. We focus on non-commer-
cial research aimed at understanding the world around us, which is 
vital to supporting conservation (Beck, 2019). Our examples con-
centrate on aspects of plant and fungal research including taxon-
omy, seed biology, ecological interactions, ecosystem services, the 
effects of climate change, and genomic studies.
1.1 | The Convention on Biological Diversity: 
establishment, development, and protocols
The CBD (1992, currently 196 Parties) is the overarching United 
Nations Convention to tackle biodiversity loss, focusing on three 
objectives: (a) the conservation of biological diversity; (b) the sus-
tainable use of the components of biodiversity; and (c) the fair and 
equitable sharing of benefits arising from the utilization of genetic 
resources (GR). The CBD recognizes the sovereign rights of States 
over their natural resources and their authority to determine access 
to GR through national legislation (Article 15 (1) CBD) and encour-
ages Parties to develop conditions for facilitated access to GR for en-
vironmentally sound uses (Article 15 (2) CBD). A major reason many 
ratified the Convention (Davis, 2018) was that the CBD mechanism 
of sharing benefits from GR would act as an incentive for countries 
to invest in conservation.
However, measures to regulate access to GR (Davis & 
Borisenko, 2017; Rosendal & Andresen, 2016) have brought criticism 
that overly complex legislation is hampering scientific research (Alves 
et al., 2018; Neumann et al., 2018; da Silva & de Oliveira, 2018; Smith, 
da Silva, Jackson, & Lyal, 2017). Although regulatory access measures 
are only one of the reasons countries are failing to see expected ben-
efits needed to support national conservation efforts (Dalle, 2015; 
Vogel, Alvarez-Berrios, Quinones-Vilches, & Medina-Muniz, 2011), 
they have a major impact. While some countries (like Australia) 
have included a facilitated access procedure for researchers doing 
non-commercial research (AUDAWP, 2020)), others have resisted 
because of concerns over keeping track of how their GR are used. 
Ethiopia's introduction of a facilitated access procedure (Negarit, 
2006; Negarit-Gazeta, 2009) (Box 1) demonstrated their expecta-
tion that this system would increase both commercial and non-com-
mercial benefits, but these have not been realized (Dalle, 2015). 
Parties to the CBD have become increasingly concerned (Neumann 
et al., 2018; Prathapan, Pethiyagoda, Bawa, Raven, & Rajan, 2018) 
that complex and time-consuming access procedures are stifling 
the non-commercial research needed to support the objectives of 
the Convention, (such as Articles 7 and 8 of the CBD) (Bockmann 
et al., 2018; Rodrigueza & Antonellib, 2009). Consequently, in the 
negotiation stage of a new ABS regime (2002–2010), Parties were 
specifically urged to address these issues (UNEP, 2010).
The CBD’s Nagoya Protocol on Access to Genetic Resources and 
Benefit Sharing (NP), agreed in 2010 and in force since 2014, has 
provided more clarity on how access legislation should be framed. 
The NP introduced a legally binding compliance regime to enforce 
benefit sharing (da Silva, 2019) and encourages Parties to implement 
“simplified measures on access for non-commercial research pur-
poses” (Article 8a NP). The aim of this was to facilitate biodiversity 
research that underpins conservation and sustainable use, and takes 
into account the need to address a change of intent (commercial/
non-commercial) for such research (Schindel & Du Plessis, 2014).
Parties to the Protocol are also to “encourage” the development 
and use of codes of conduct, guidelines and best practices or stan-
dards in relation to ABS (NP Article 20 (1)), these can be crucial in 
building trust in non-commercial research. To ensure compliance with 
national legislation (NP Article 6(3)(e)), parties should issue a permit, 
as evidence that access to GR was based on prior informed consent 
and mutually agreed terms. Parties are required to make information 
• Our results suggest while the regulatory systems are perceived as hindering re-
search and conservation, regulatory mechanisms enabling responsible research 
are becoming increasingly functional. We argue that functional and transparent 
systems are needed for both regulators and researchers, to ensure that non-com-
mercial research can continue smoothly, and present conclusions to support re-
search for the benefit of all countries and partners involved, through appropriate 
frameworks for implementation and reporting.
K E Y W O R D S
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on the permit available to the ABS Clearing-House (ABSCH) (Article 
14 (2)(c)), which constitutes an “Internationally Recognized Certificate 
of Compliance” (IRCC). The IRCC is a major innovation of the NP and 
is key to the compliance regime of the ABS system.
1.2 | Convention on International Trade in 
Endangered Species (CITES)
CITES (1975, currently 183 Parties) establishes regulatory meas-
ures for Parties to prevent species decline due to international 
trade (CITES, 2020). CITES regulates the international trade of 
over 30,000 plant species, and while the Conference of the Parties 
agrees that species of fungi are covered by CITES, to-date none 
have been listed. Permits allowing the trade in CITES listed species 
can only be issued if CITES Authorities are satisfied that trade will 
not be detrimental to the survival of the species and the speci-
mens were legally obtained.
To accommodate research, CITES recognized that an exemp-
tion from the general permit system was needed to facilitate 
research in CITES specimens (Article VII, paragraph 6 of CITES)
(CITES, 2020), and the establishment of the Registered Scientific 
Institute (RSI) scheme (Roberts & Solow, 2008). The promotion and 
implementation of the RSI scheme in each Party is a responsibility 
of the individual state, and thus, it may be enacted differently. For 
instance, in criteria and lengths of validity, or in reporting mech-
anisms to the CITES Authorities. Despite the exemption, many 
scientists have expressed that permits can be costly and time con-
suming to obtain. A long-standing concern has been that the RSI 
scheme does not work, ultimately impeding the free movement 
of specimens for scientific purposes (Raven, 2007; Roberts, 2005; 
Zelenko, 2005).
Below we explore the extent to which these mechanisms (ABS 
for CBD, and RSI for CITES) have been effective in supporting bio-
diversity research (Pauchard, 2018), examining claims that interna-
tional policy frameworks have had a detrimental effect (Wynberg 
& Laird, 2018).
2  | METHODS
We focused on 20 countries where analyses of ABS legislation data 
were available (Sirakaya, 2019). They were selected based on biodi-
versity richness, signatory status to the NP, age of ABS framework, 
economic status and we also aimed to include at least one country 
per continent. We examined trends from the ABSCH website of the 
CBD, (https://absch.cbd.int/reports) to analyse access, looking at 
whether countries had introduced favourable measures on access 
for non-commercial research purposes (Figure 1) and whether this 
had any impact on levels of the collection of plant and fungal mate-
rial. By the term “favourable” here, we mean any measure (such as 
quicker time-frames, simpler systems, shorter application forms, less 
onerous procedures) that makes access quicker or easier for non-
commercial researchers. For instance, a country switching from an 
in-country paper-based system to an electronic system accepting 
global applications. This phrase includes both measures put in place 
following the CBD’s call for Parties to “create conditions to facilitate 
access to genetic resources for environmentally sound uses” and 
later measures in response to the NP to introduce “simplified meas-
ures on access for non-commercial research purposes”.
Secondly, beyond our focus countries, we gathered the total 
number of IRCCs that have been issued by Parties (as at February 
2020) as an indication of research carried out since the NP came 
into force (October 2014). All data were downloaded (Figure 2) 
F I G U R E  1   Differences in access 
procedures among the countries 
surveyed. The term “favorable” here 
means any measure (such as quicker 
time-frames, simpler systems, shorter 
application forms, less onerous 
procedures) that makes access quicker or 
easier for non-commercial researchers. 
Due to the select sampling of countries 
there may be an undue bias depicted in 
the diagram  
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and a full analysis of all IRCCs (2014 to 2019) of two chosen coun-
tries, Kenya and Vietnam, was carried out as an exemplar study to 
highlight non-commercial research. Individual case studies were 
obtained from experts in the following countries: Ethiopia (Box 1), 
Brazil (Box 2) and South Africa (Box 3).
The CITES website was consulted (cites.org) to identify the RSIs 
available in each country. A questionnaire was emailed to the CITES 
Management and Scientific Authorities of the applicable 20 study 
countries (Sirakaya, 2019) and the European Member States, of which 
the United Kingdom (UK) was a part at the time of writing (Table 1). 
The consultation was carried out in early January 2020, for 4 weeks, 
and contained 10 open questions. Participants were asked to provide 
additional information on the use of the RSI scheme and annual reports 
if available (and applicable as a national requirement). Only completed 
reports, covering the five years from 2014 to 2019, were analysed.
3  | RESULTS
3.1 | Favorable access procedures
Australia was one of the first to introduce a simpler permitting sys-
tem for non-commercial research, using a standard form to minimize 
transaction costs in 2000. In 1998, Costa Rica introduced access 
legislation to encourage research, with an online system and stand-
ard permit forms (Figure 1). Ethiopia adopted domestic legislation 
facilitating access for non-commercial purposes before the adoption 
of the NP (Box 1).
Since 2014, several more countries have introduced “simplified” 
measures for non-commercial research. France, Spain, Malaysia, 
and the Republic of Korea all introduced legislation in 2017, and the 
Dominican Republic in 2018 (Figure 1). Under its original access legis-
lation, Brazil (Provisional Act nº 2.186-16/2001;), did not require au-
thorization for fundamental research (da Silva & de Oliveira, 2018), 
however, the 2015 Biodiversity Law, now requires all research to 
be registered electronically (SisGen). Operational since November 
2017, this has attracted some criticism from Brazilian scientists 
(Box 2). Several countries, including Namibia, Malaysia, and Vietnam 
(Figure 1), introduced simplified access procedures for non-com-
mercial research, but only for research taking place in-country, for 
national researchers, or researchers based at national institutions. 
Restricting simplified access procedures in this way suggests that 
countries remain concerned about how they can track the use of GR 
once these resources have been exported.
There is evidence that, despite some simplified measures, 
legal obstacles still exist for non-commercial research scientists 
(Bockmann et al., 2018). The demarcation between commercial and 
non-commercial research is unclear, guidance is needed to enable 
countries to enact adequate measures, ensuring changes of use or 
intent are tracked and benefits are shared (Pauchard, 2018). Legal 
certainty and effective user country compliance procedures are all 
vital (Beck, 2019; Wynberg & Laird, 2018), while limited capacity, 
lack of legal enforcement and follow-up mechanisms for ABS pro-
cedures have also been identified as critical gaps obstructing proper 
implementation (Dalle, 2015).
3.2 | Internationally Recognized Certificates of 
Compliance (IRCC)
As of 1st February 2020, the ABSCH website had registered more 
than double the total number of IRCCs registered six months 
F I G U R E  2   Total number of 
Internationally Recognized Certificates 
of Compliance (IRCCs) and type for each 
focal country. †: According to the 
Ethiopian Biodiversity Institute (EBI), 
895 IRCCs have been granted for users 
to access GR of the country for both 
commercial and non-commercial research 
(13 and 882 respectively). Due to 
technical difficulties, these have not yet 
been uploaded to the Access and Benefit 
Sharing Clearing House (ABSCH)
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earlier (1,192 in Figure 2) (Aviles-Polanco, Jefferson, Almendarez-
Hernandez, & Beltran-Morales, 2019). This is possibly due 
to more focus on the NP within the CBD Global Biodiversity 
Framework in 2020. Eight of our 20 focal countries had uploaded 
IRCCs (Figure 2), representing 95% of the total. Three IRCCs were 
issued for non-commercial purposes with potential commerciali-
zation, 59% for non-commercial and the remaining 41% were for 
commercial purposes (Figure 1). These figures represent only 4% 
of the Parties who have signed up to the NP. As India had not 
identified the uses of their IRCCs, these were excluded, and the 
following results refer to the remaining 652 IRCCs. Less than a 
third of the Kenyan non-commercial IRCCs issued were for re-
search related to plants or fungi (Figure 3). Similarly, just under 
half of the IRCCs in Vietnam were for research related to plants 
(Figure 3).
We assessed the source and users of GR, in Kenya, 92% of all 
non-commercial research permits were issued by Government 
agencies (n = 12) and one issued by an academic institute (n = 1). 
Vietnamese permits for plant and fungi GR were issued by aca-
demic or research institutions (n = 12), for material obtained from in 
situ sources, with only one permit, issued by a museum, for ex situ 
sourced material.
Half of the 12 permit holders for plant and fungi research 
in Kenya were based in-country. Foreign users accessing plant and 
fungi GR in Kenya were from USA (n = 3) and China (n = 1). The 
users of the remaining two IRCC permits for plant and fungi re-
search in Kenya were confidential (n = 2). In contrast, 13 users 
accessing plant and fungi GR in Vietnam were foreign, represent-
ing five countries: South Korea (n = 9), China, Belgium, Germany, 
and Ireland (n = 1 each). These relatively small numbers probably 
reflect that countries have only recently engaged with the IRCC 
process.
BOX 1 Case study: Ethiopia
The Ethiopian government enacted ABS Proclamation No. 
482/2006 and its Regulation in 2009. The Proclamation 
relates to in situ and ex situ GR and associated traditional 
knowledge. It sets out a clear system with differentiated re-
quirements for commercial and non-commercial research.
Applications for non-commercial research must be in 
accordance with the form specified in Annex II of the 
Regulation (Negarit-Gazeta, 2009) and do not need de-
tailed information on finance, the use of GR or its deriva-
tives. Furthermore, there is no commercial benefit sharing 
arrangement, although non-monetary benefits are ex-
pected (i.e. co-authored publications and data sharing). 
The researcher retains the material for the research period 
only and must return unused material to the provider on 
completion of the research. Access permits for non-com-
mercial research are issued in under an hour and are free.
According to the legislation, any foreign user of GR for 
non-commercial use needs to additionally obtain an export 
permit, which is an official document authorizing export 
of the GR from Ethiopia. A Material Transfer Agreement 
(MTA) is then made between the host organization, the re-
searcher and the Provider (Ethiopian Biodiversity Institute). 
Under the Ethiopian legislation foreign researchers need 
to submit an official letter from their National Competent 
Authority (NCA), assuring they will “uphold and enforce” 
the Ethiopian access legislation. Due to divergent inter-
pretations of the role of NCAs under the NP, user country 
NCAs have found this impossible to comply with and this 
has practically halted the export of material from Ethiopia 
for research.
BOX 2 Case study: Brazil
In Brazil, not a Party to the NP, current ABS legislation 
regulates access to genetic heritage (GH) and associ-
ated traditional knowledge for research, technological 
development, and economic use of products. The wider 
term “genetic heritage” here means information as well 
as physical material (da Silva, 2019). Benefit sharing is 
only required when there has been commercial use. The 
previous “authorization” required by previous legislation 
(Provisional Act nº 2,186-16/2001), has been replaced by 
the need to register all research in the online National 
System for Genetic Heritage and Associated Traditional 
Knowledge Management (SisGen), which can be done 
during the research and technological development with 
GH. Foreign researchers must be associated with pub-
lic or private Brazilian scientific and technological re-
search institutions in order to register research involving 
Brazilian GH.
The current Brazilian ABS legislation has been argued to 
add complexity for non-commercial researchers (Alves 
et al., 2018) and in particular for the depositing of bacteria 
in international culture collections meaning that bacte-
rial taxonomists have been unable to publish the descrip-
tion of new bacterial species (Pers. comm M da Silva). 
According to the International Code of Nomenclature 
of Prokaryotes, for acceptance of a new bacteria spe-
cies, a culture of the type strain should be deposited in 
two different countries’ publicly accessible culture col-
lections, where unrestricted subcultures must be avail-
able. Brazilian research organizations are working with 
the Environmental Ministry within the Sectoral Chamber 
of the Academy of the Genetic Heritage Management 
Council (CGEN) to address these issues (da Silva, 2019).
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3.3 | Registered scientific institutions (RSIs)
To date, 74 Parties of CITES have registered their scientific institu-
tions with the CITES Secretariat, with a total of 857 scientific in-
stitutions being listed in the past five years (2014–2019). Australia, 
Austria, Denmark, Italy, Germany, Spain, and the UK have all 
registered new scientific institutions, from one RSI registered in 
Denmark to 17 in Australia (Figure 4).
Many respondents provided confirmation of RSI successes and 
challenges:
• Six countries encourage scientific institutions and scientists to 
register with the scheme;
• Spain has a streamlined application procedure for scientific ex-
change of materials;
• Germany has detailed information and guidance about their RSI 
scheme on the Scientific Authority homepage, and actively ad-
vises scientists;
• Austria, Australia, Denmark, and the UK contact scientific institutions 
about the RSI scheme, and deal with ad-hoc registration requests;
• Ethiopia, the Philippines, and Italy stated that the promotion of 
RSI scheme is inadequate;
• Croatia, Ethiopia, Italy, Germany, Greece, Philippines, and 
Denmark have not encountered difficulties in implementation;
• Austria and Croatia criticized the scheme as it does not encourage 
new research on CITES taxa;
• Norway, UK, Spain, and Denmark received between 5% and 10% 
of the total number of expected annual reports;
• The UK noted most institutions do not use the scheme regularly, 
and some failed to record both incoming and outgoing exchanges;
• Eleven consulted Parties did not have recent reports to share or 
were otherwise not able to share these. The UK shared annual 
reports for the five years ranging 2014 to 2019 from the Royal 
Botanic Gardens, Kew (Figure 5).
Parties consulted noted the registration of institutions involved 
in non-commercial research is necessary, but had difficulties using 
the scheme or interpreting its language i.e. the scheme could not be 
used where CITES was not implemented in both countries involved 
in the process of exchange. Respondents noted the definition of an 
eligible “‘specimen” for the simplified procedure is unclear to the 
RSIs involved, and widespread misunderstanding of conditions of 
use exist. Some parties felt the registration and inventory process 
for scientific collections of an institution involves more effort and 
time, compared to applying for a one-time CITES permit.
BOX 3 Case study: South Africa
South Africa has an access permitting system that is simi-
lar for both commercial and non-commercial research 
(Pauchard, 2018). The conservation authority, South 
African National Parks (SANParks) developed its research 
permit application system for both domestic and foreign 
scientists within the provision of the National Environment 
Management Act for Protected Areas (NEMPAA). 
Guidance documents and templates are available online 
for the scientific community's use. SANParks Scientific 
Services review applications for their relevance and con-
tribution to management objectives and approve or reject 
on a quarterly basis. Mostly applications are amended, 
and the research is permitted. The main inconvenience to 
SANParks in the processing of permits arises from hasty 
or last-minute submissions, often lacking information 
critical for proper review. Consequently, undue pressure 
is placed on SANParks staff by applicants, who have not 
planned for aspects of legislation compliance. Overall, the 
research application framework for permission to conduct 
research in SANParks works well despite some late or in-
adequate submissions. The Cape Research Centre (Fynbos 
and Succulent Karoo Biomes) received 391 applications 
from 2011–2019 and of these only nine were rejected, a 
98% approval rate over eight years. None of these permits 
has been uploaded to the ABSCH, as non-commercial re-
search is exempted from the ABS regime in South Africa 
(Pauchard, 2018).
CITES Parties of the European Union 
with at least one Registered Scientific 
Institution
CITES Parties (identified by Sirakaya, 2019) with at 









TA B L E  1   List of the CITES Parties 
consulted, 12 Parties responded with full 
completed questionnaires
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4  | DISCUSSION
Access to GR for research and conservation to halt the global loss of 
biodiversity is urgently required. Despite over 250 years of botanical 
and taxonomic research, less than 20% of terrestrial species diver-
sity have been catalogued (Thomson et al., 2018). To accelerate bio-
diversity research and conservation, strong international research 
partnerships are required, supported by clear national legislation 
covering access and compliance to facilitate research and ensure 
benefit sharing.
Fears of illegal acquisition of GR have led to restrictive measures 
and distrust of research institutions (Reichman, 2019). Restrictions 
on access to work with species in situ and ex situ create barriers to 
important international collaborative research. The CBD, in Article 
15 (6) states that scientific research should be carried out with the 
“full participation of and where possible in” provider countries. 
Efforts should be made to support this and otherwise, research 
should lead to non-monetary benefit sharing, such as the training of 
taxonomists in situ (Jojan, Dsouza, Mukerjee, Rao, & Shanker, 2018). 
Providers in biodiverse countries have limited capacity for tracking 
F I G U R E  3   Non-Commercial 
Internationally Recognized Certificates 
of Compliance (IRCCs) issued by Kenya 
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Non-commercial IRCCs issued by Kenya and Vietnam 
according to genec resource
Plants in Vietnam Plants/fungi in Vietnam Other in Vietnam
Plants in Kenya Plants/fungi in Kenya Other in Kenya
F I G U R E  4   Map showing countries with ABS under the CBD and those with CITES RSIs
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F I G U R E  5   Movement of CITES plant specimens for RSI Royal Botanic Gardens Kew in the UK. Between 2014 and 2019, Kew Gardens 
donated, exchanged, or loaned 725 non-commercial CITES scientific specimens with several RSIs around the globe: herbarium specimens, 
seeds, DNA samples, leaf samples, wood samples, spirit specimens, illustrations, and rooted cutting of specimens. During the same period, 
Kew Gardens received 253 herbarium and spirit of CITES scientific specimens
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and enforcing agreed terms and conditions of national ABS proce-
dures meaning user country compliance measures are vital to build 
trust and ensure that benefits are shared and actions are taken if 
not. Simultaneously, the non-commercial research sector needs to 
continue to work hard to develop and use best practices and sec-
toral codes of conduct (Davis, 2018) ensuring that they can navigate 
the developing national legislations, ABS agreements are in place 
and prior informed consent obtained (Kariyawasam & Tsai, 2018; 
Wynberg, 2017). Effective implementation of compliance measures, 
legal transparency, and certainty will be critical to deliver the CBD 
objectives.
IRCCs provide a vital means to track the use of GR, support-
ing compliance, and identifying any change of use. Our research 
shows that the use of the ABSCH IRCC has doubled between 
August 2019 and February 2020. However, as of 1 February 2020, 
only 19 of 123 Parties to the NP have uploaded IRCCs, and so the 
research covered is only a tiny fraction of what is carried out and 
required. We acknowledge the increase in IRCCs detected does 
not necessarily mean more research is taking place, but a reflec-
tion that Parties are engaging with the IRCC process. However, 
we predict the ABSCH will become an important source of in-
formation and must adapt accordingly. Currently the platform is 
not easily searchable. As data increases with more uploads, we 
suggest modifications to ensure it is a useable tool, a view sup-
ported in recent discussions of the Informal Advisory Committee 
to the ABS Clearing-House (CBD, 2020). IRCCs provide evidence 
of research types being conducted with clear agreements, and 
this article is the first to quantitatively analyse them for plant and 
fungal research.
We found that there is potential for simplified access procedures 
to have an increasing benefit for non-commercial research. We note 
the proportions of commercial and non-commercial permits vary 
greatly between countries, with India and South Africa (Box 3) up-
loading much smaller proportions of permits for non-commercial 
research. Reflecting the variety of ABS legislation implemented at 
a national level and different approaches to what constitutes ac-
cess (Laird et al., 2020), it appears that certain national legislation 
is already providing easier access procedures for non-commercial 
research. In many cases, non-commercial research will not activate 
a country's access procedures. This occurs in South Africa (Box 3), 
where a smaller proportion of non-commercial research permits 
have been uploaded as certain non-commercial research does not 
meet access requirements. However, in Ethiopia, where national 
access legislation covers non-commercial research a higher propor-
tion have been uploaded. It may be countries do not upload their 
non-commercial research permits due to lack of capacity or tech-
nological difficulties, or especially if they are too numerous. More 
investment is needed, both in terms of infrastructure and training, to 
ensure that all countries have the capacity to use and upload IRCCs 
to the ABSCH. Examples of such infrastructure include improved 
connectivity to the internet and computer equipment, as well as 
trained technicians to capture data, but also training in the develop-
ment of in-country systems.
Our analyses of IRCCs from Kenya and Vietnam show that 
only a small proportion of benefit sharing is related to plants and 
fungi, despite their critical links to livelihoods (Dhanda, Williams, & 
Cowell, 2019) and their potential to address sustainable develop-
ment goals (Antonelli, Smith, & Simmonds, 2020). Further analysis 
of IRCCs from more countries will provide a better representation of 
the data and could aid in determining the impacts on conservation 
critical research.
Ultimately, whilst aimed at correcting centuries of inequitable 
use of biological resources (Wynberg & Laird, 2018), current ABS 
policy processes are seen as inflexible (Pisupati & Bavikatte, 2014; 
Prathapan et al., 2018). There is no clear way to differentiate the 
point at which non-commercial research becomes commercial 
(Neumann et al., 2018), and this has made it hard for provider coun-
tries to create workable national legislation. Consequently, there 
have been calls for the current ABS system, based on physical access 
to material and the bilateral contract model, to be reappraised (Laird 
et al., 2020).
We had mixed findings on the CITES RSI scheme as an exam-
ple of a process designed to expedite and facilitate non-commercial 
research. Although a list of RSIs is available on the CITES website, 
it is only updated every five years as the validity of the registra-
tion within each country is different. There is currently no formal 
reporting mechanism to the CITES Secretariat to check if RSIs are 
compliant, yet some Parties conduct audits and review reports. The 
data from the UK’s annual report proved useful in identifying and 
confirming research collaborations (Dhanda et al., 2019) (Figure 5). 
Many respondents answered favorably about the scheme as it eases 
access to collections, improves exchange times, and reduces admin-
istrative burdens. However, the scheme also appears to be a signif-
icant hurdle for scientific institutions by only providing exemption 
to specimens already part of a collection when an institute registers 
and not to specimens added after registration, thus restricting future 
research.
A standard set framework such as CITES has for RSIs could lead 
to the creation of a central database of registered institutions. Such 
a system would require users to adopt agreed best practices govern-
ing collection, curation, and collaboration, to ensure measures are 
in place to track (and secure approval for) changes of use. There is 
scope within the NP (Article 20) for Parties to “consider the adop-
tion” of best practice standards and codes of conduct which could be 
the basis for research institutes to register and adhere to.
5  | CONCLUSIONS
We have shown that the use of IRCCs is key in the compliance re-
gime of the NP and encourage measures to increase the capacity 
of Parties to use the ABSCH platform, uploading information and 
IRCCs. Once more IRCCs are available, we recommend further 
analysis of the data, to ascertain patterns in commercial and non-
commercial research. To support this, the platform can be modified 
for more functionality to work as a searchable tool. We also hope 
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that Parties are encouraged to re-evaluate the benefits of the CITES 
RSI scheme, promoting it adequately with scientists and researchers 
who use scientific specimens for research purposes. We would sup-
port the creation of a standard and simplified registration template, 
addressing compliance measures, such as reporting and new speci-
men additions to existing collections.
While we hope this article will encourage providers of GR to im-
plement simplified access measures for non-commercial research to 
support the vital conservation work that is needed, we recognize 
that to support compliance, researchers need to provide information 
to aid Parties in differentiating between commercial and non-com-
mercial research. We urge researchers to follow the many estab-
lished codes of conduct, guidelines, and best practices to build trust 
and develop strong international partnerships.
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